A New Approach to Assess Blinding for Transcranial Direct Current Stimulation Treatment in Patients with Fibromyalgia. A Randomized Clinical Trial

Correct blinding is essential for preventing potential biases. The aim of this study was to assess the blinding of participants and a therapist following treatment with transcranial direct current stimulation in subjects with fibromyalgia using James’ and Bang’s blinding indexes. Eighty subjects wer...

Full description

Bibliographic Details
Main Authors: Rubén Arroyo-Fernández, Juan Avendaño-Coy, Rafael Velasco-Velasco, Rocío Palomo-Carrión, Elisabeth Bravo-Esteban, Asunción Ferri-Morales
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/11/10/1335
_version_ 1797515124711358464
author Rubén Arroyo-Fernández
Juan Avendaño-Coy
Rafael Velasco-Velasco
Rocío Palomo-Carrión
Elisabeth Bravo-Esteban
Asunción Ferri-Morales
author_facet Rubén Arroyo-Fernández
Juan Avendaño-Coy
Rafael Velasco-Velasco
Rocío Palomo-Carrión
Elisabeth Bravo-Esteban
Asunción Ferri-Morales
author_sort Rubén Arroyo-Fernández
collection DOAJ
description Correct blinding is essential for preventing potential biases. The aim of this study was to assess the blinding of participants and a therapist following treatment with transcranial direct current stimulation in subjects with fibromyalgia using James’ and Bang’s blinding indexes. Eighty subjects were randomly allocated either active or sham stimulation groups in an intervention of five sessions lasting 20 min each. A questionnaire was delivered to both the therapist and patients after the last session to record their guess of which treatment had been applied. No differences between the groups were noted at baseline in terms of demographic or clinical data. James’ BI was 0.83 (CI 95%: 0.76–0.90) for the patients and 0.55 (CI 95%: 0.45–0.64) for the therapist. Bang’s BI for subjects was −0.08 (CI 95%: −0.24–0.09) and −0.8 (CI 95%: −0.26–0.1) for the active and sham transcranial direct current stimulation groups, respectively. Bang’s BI for the therapist was 0.21 (CI 95%: −0.02–0.43) and 0.13 (CI 95%: −0.09–0.35) for the active and sham transcranial direct current stimulation groups, respectively. Protocols of active and sham transcranial direct current stimulation applied in this study have shown satisfactory blinding of the therapist and subjects with fibromyalgia.
first_indexed 2024-03-10T06:41:10Z
format Article
id doaj.art-21dbb0bf9b3046b28acd49baab5772d4
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-03-10T06:41:10Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-21dbb0bf9b3046b28acd49baab5772d42023-11-22T17:37:36ZengMDPI AGBrain Sciences2076-34252021-10-011110133510.3390/brainsci11101335A New Approach to Assess Blinding for Transcranial Direct Current Stimulation Treatment in Patients with Fibromyalgia. A Randomized Clinical TrialRubén Arroyo-Fernández0Juan Avendaño-Coy1Rafael Velasco-Velasco2Rocío Palomo-Carrión3Elisabeth Bravo-Esteban4Asunción Ferri-Morales5Physiotherapy Unit, Nª Sª del Prado Hospital, 45600 Talavera de la Reina, SpainFaculty of Physiotherapy and Nursing, University of Castilla-La Mancha, 45071 Toledo, SpainFaculty of Physiotherapy and Nursing, University of Castilla-La Mancha, 45071 Toledo, SpainFaculty of Physiotherapy and Nursing, University of Castilla-La Mancha, 45071 Toledo, SpainFaculty of Physiotherapy and Nursing, University of Castilla-La Mancha, 45071 Toledo, SpainFaculty of Physiotherapy and Nursing, University of Castilla-La Mancha, 45071 Toledo, SpainCorrect blinding is essential for preventing potential biases. The aim of this study was to assess the blinding of participants and a therapist following treatment with transcranial direct current stimulation in subjects with fibromyalgia using James’ and Bang’s blinding indexes. Eighty subjects were randomly allocated either active or sham stimulation groups in an intervention of five sessions lasting 20 min each. A questionnaire was delivered to both the therapist and patients after the last session to record their guess of which treatment had been applied. No differences between the groups were noted at baseline in terms of demographic or clinical data. James’ BI was 0.83 (CI 95%: 0.76–0.90) for the patients and 0.55 (CI 95%: 0.45–0.64) for the therapist. Bang’s BI for subjects was −0.08 (CI 95%: −0.24–0.09) and −0.8 (CI 95%: −0.26–0.1) for the active and sham transcranial direct current stimulation groups, respectively. Bang’s BI for the therapist was 0.21 (CI 95%: −0.02–0.43) and 0.13 (CI 95%: −0.09–0.35) for the active and sham transcranial direct current stimulation groups, respectively. Protocols of active and sham transcranial direct current stimulation applied in this study have shown satisfactory blinding of the therapist and subjects with fibromyalgia.https://www.mdpi.com/2076-3425/11/10/1335transcranial direct current stimulationfibromyalgiaplaceboblindingJames’ indexBang’s index
spellingShingle Rubén Arroyo-Fernández
Juan Avendaño-Coy
Rafael Velasco-Velasco
Rocío Palomo-Carrión
Elisabeth Bravo-Esteban
Asunción Ferri-Morales
A New Approach to Assess Blinding for Transcranial Direct Current Stimulation Treatment in Patients with Fibromyalgia. A Randomized Clinical Trial
Brain Sciences
transcranial direct current stimulation
fibromyalgia
placebo
blinding
James’ index
Bang’s index
title A New Approach to Assess Blinding for Transcranial Direct Current Stimulation Treatment in Patients with Fibromyalgia. A Randomized Clinical Trial
title_full A New Approach to Assess Blinding for Transcranial Direct Current Stimulation Treatment in Patients with Fibromyalgia. A Randomized Clinical Trial
title_fullStr A New Approach to Assess Blinding for Transcranial Direct Current Stimulation Treatment in Patients with Fibromyalgia. A Randomized Clinical Trial
title_full_unstemmed A New Approach to Assess Blinding for Transcranial Direct Current Stimulation Treatment in Patients with Fibromyalgia. A Randomized Clinical Trial
title_short A New Approach to Assess Blinding for Transcranial Direct Current Stimulation Treatment in Patients with Fibromyalgia. A Randomized Clinical Trial
title_sort new approach to assess blinding for transcranial direct current stimulation treatment in patients with fibromyalgia a randomized clinical trial
topic transcranial direct current stimulation
fibromyalgia
placebo
blinding
James’ index
Bang’s index
url https://www.mdpi.com/2076-3425/11/10/1335
work_keys_str_mv AT rubenarroyofernandez anewapproachtoassessblindingfortranscranialdirectcurrentstimulationtreatmentinpatientswithfibromyalgiaarandomizedclinicaltrial
AT juanavendanocoy anewapproachtoassessblindingfortranscranialdirectcurrentstimulationtreatmentinpatientswithfibromyalgiaarandomizedclinicaltrial
AT rafaelvelascovelasco anewapproachtoassessblindingfortranscranialdirectcurrentstimulationtreatmentinpatientswithfibromyalgiaarandomizedclinicaltrial
AT rociopalomocarrion anewapproachtoassessblindingfortranscranialdirectcurrentstimulationtreatmentinpatientswithfibromyalgiaarandomizedclinicaltrial
AT elisabethbravoesteban anewapproachtoassessblindingfortranscranialdirectcurrentstimulationtreatmentinpatientswithfibromyalgiaarandomizedclinicaltrial
AT asuncionferrimorales anewapproachtoassessblindingfortranscranialdirectcurrentstimulationtreatmentinpatientswithfibromyalgiaarandomizedclinicaltrial
AT rubenarroyofernandez newapproachtoassessblindingfortranscranialdirectcurrentstimulationtreatmentinpatientswithfibromyalgiaarandomizedclinicaltrial
AT juanavendanocoy newapproachtoassessblindingfortranscranialdirectcurrentstimulationtreatmentinpatientswithfibromyalgiaarandomizedclinicaltrial
AT rafaelvelascovelasco newapproachtoassessblindingfortranscranialdirectcurrentstimulationtreatmentinpatientswithfibromyalgiaarandomizedclinicaltrial
AT rociopalomocarrion newapproachtoassessblindingfortranscranialdirectcurrentstimulationtreatmentinpatientswithfibromyalgiaarandomizedclinicaltrial
AT elisabethbravoesteban newapproachtoassessblindingfortranscranialdirectcurrentstimulationtreatmentinpatientswithfibromyalgiaarandomizedclinicaltrial
AT asuncionferrimorales newapproachtoassessblindingfortranscranialdirectcurrentstimulationtreatmentinpatientswithfibromyalgiaarandomizedclinicaltrial